Table 1.
Baseline characteristics of participants.
| EO group (n = 41) | Control group (n = 40) | P value | |
|---|---|---|---|
| Age (year) | 56.05 ± 10.02 | 51.18 ± 9.5 | 0.02 |
| (mean ± SD) | |||
| Sex, n (%) | Male: 20 (48.8) | 25 (62.5) | 0.26 |
| Female: 21 (51.2) | 15 (37.5) | ||
| Marriage, n (%) | Single: 0 | 2 (5) | 0.24 |
| married: 41 (100) | 2 (5) | ||
| BMI (mean ± SD) | 28.08 (4.8) | 27.04 (3.9) | 0.3 |
| Duration of HTN (months) (mean ± SD) | 85.57 (83.36) | 69.16 (65.25) | 0.51 |
| Duration of use of anti-HTN drugs (months) (mean ± SD) | 65.47 (75.94) | 60.85 (67.21) | 0.84 |
| Smoking, n (%) | 7 (17.1) | 11 (27.5) | 0.29 |
EO: Emblica officinalis, SD: standard deviation, BMI: body mass index, and HTN: hypertension.